Sei Investments CO Orchard Therapeutics PLC Transaction History

Sei Investments CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $21,054 - $39,100	-50,129 Reduced 59.48%	34,151 $20,000
Q1 2022 May 13, 2022	SELL	$0.7 - $1.51 $67,981 - $146,645	-97,116 Reduced 53.54%	84,280 $60,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $32,308 - $62,109	27,852 Added 18.14%	181,396 $239,000
Q3 2021 Nov 12, 2021	SELL	$2.24 - $4.29 $94,082 - $180,184	-42,001 Reduced 21.48%	153,544 $353,000
Q2 2021 Aug 06, 2021	BUY	$4.39 - $7.23 $358,487 - $590,401	81,660 Added 71.7%	195,545 $858,000
Q1 2021 May 12, 2021	BUY	$4.39 - $9.08 $311,839 - $644,988	71,034 Added 165.77%	113,885 $827,000
Q4 2020 Feb 08, 2021	BUY	$3.86 - $5.07 $27,425 - $36,022	7,105 Added 19.88%	42,851 $185,000
Q3 2020 Nov 06, 2020	SELL	$4.11 - $6.45 $10,340 - $16,228	-2,516 Reduced 6.58%	35,746 $147,000
Q2 2020 Aug 17, 2020	BUY	$5.75 - $11.99 $220,006 - $458,761	38,262 New	38,262 $230,000
Q2 2020 Aug 11, 2020	SELL	$5.75 - $11.99 $228,355 - $476,170	-39,714 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $224,384 - $623,906	39,714 New	39,714 $299,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.